Active substance
Tylosin tartrate.
Indications
Pigs:
Treatment and metaphylaxis of enzootic pneumonia caused by M. hyopneumoniae susceptible to tylosin.
Treatment and metaphylaxis of porcine intestinal adenopathy (ileitis) caused by L. intracellularis susceptible to tylosin.
Poultry:
- Chickens: Treatment and metaphylaxis of chronic respiratory disease (CRD) caused by M. gallisepticum and M. sinoviae susceptible to tylosin. Treatment of necrotic enteritis caused by Clostridium perfringens susceptible to tylosin.
- Turkeys: Treatment and prevention of chronic respiratory disease (CRD) caused by M. maleagridis.
Pre-ruminant calves:
Treatment and metaphylaxis of pneumonia caused by M. bovis and P. multocida.
Dosage and route of administration
To be administered in drinking water, milk or artificial milk replacer.
Pigs:
Treatment and metaphylaxis of enzootic pneumonia: 31.25 mg of medicinal product/kg b.w., for 3-10 days.
Treatment and metaphylaxis of porcine intestinal adenopathy (ileitis): 15.625-31.25 mg of medicinal product/kg b.w., for 3-10 days.
Chickens and turkeys:
Treatment and metaphylaxis of chronic respiratory disease: 137.5 mg of medicinal product/kg b.w./day, for 5 days.
Treatment of necrotic enteritis: 25-50 mg of medicinal product/kg b.w., for 5 days.
Pre-ruminant calves:
Treatment and metaphylaxis of pneumonia: 25 mg of medicinal product/kg b.w., twice a day, which corresponds to a daily dose of 50 mg of medicinal product/kg b.w./day, for 7-14 days.
Withdrawal period
Pigs: Meat: 1 day.
Chickens: Meat: 0 days. Eggs: 0 days.
Turkeys: Meat: 5 days.
Cattle (pre-ruminant calves): Meat: 21 days.
Presentations
625 g bag.
Registration n° 4083 ESP
